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Lebanese populationAbstract Cardiovascular disease is a major cause of morbidity and mortality world-
wide, hypertension being one of their most prevalent risk factors. Information on
health related quality of life (QOL) of hypertensive individuals in Lebanon is lacking.
Our objectives were to evaluate QOL of hypertensive patients compared with non-
hypertensive subjects and to suggest possible predictors of QOL in Lebanon. We con-
ducted a case control study among individuals visiting outpatient clinics. Quality of
life was assessed using the eight item (SF-8) questionnaire administered face to face
to the study population, applied to hypertensive (N = 224) and non-hypertensive
control (N = 448) groups. Hypertensive patients presented lower QOL scores in all
domains, particularly in case of high administration frequency and occurrence of
drug related side effects. Among hypertensive patients, QOL was significantly
decreased with the presence of comorbidities (b = 13.865, p = 0.054), daily fre-
quency of antihypertensive medications (b = 8.196, p < 0.001), presence of drug
side-effects (b = 19.262, p = 0.031), older age (b = 0.548, p < 0.001), female gen-
der (b = 21.363, p = 0.05), lower education (b = 22.949, p = 0.006), and cigar-
ettes smoked daily (b = 0.726, p < 0.001); regular sport activity (b = 23.15,
p < 0.001) significantly increased quality of life. These findings indicate the neces-
sity for health professionals to take these factors into account when treating hyper-
tensive patients, and to tackle special subgroups with attention to their
deteriorated QOL.
ª 2015 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Cardiovascular disease (CVD) is a major cause of
morbidity and mortality worldwide [1,2]. Globally,
they account for approximately 17 million deaths
328 M. Khalifeh et al.a year [3]. Hypertension is considered a major car-
diovascular risk factor with high prevalence in
almost all countries, with a slow and silent progres-
sion [4]. Complications of hypertension are highly
prevalent and account for 9.4 million deaths world-
wide every year [5]. On another hand, the dramatic
increase of longevity has brought attention that it
should be accompanied with improvements in
health-related quality of life (QOL). The World
Health Organization (WHO) has summarized these
concerns, stating that ‘‘adding years to life is an
empty victory without adding life to years’’ [6].
Regardless of the condition type, patients QOL is
adversely affected by chronic illness [7]; this is an
important consideration in the management of
asymptomatic conditions such as hypertension [8].
With this regard, studies assessing the impact of
hypertension on QOL had been carried out in vari-
ous countries. For example, Roca-Cusachs et al.
assessed the impact of QOL clinical variables and
reported that hypertensive patients experienced
a significant reduction in QOL when compared with
normotensive individuals [9]. Li et al. studied the
Chinese population and observed that QOL was
higher in normotensive individuals [10]. Bardage
and Isacson found that QOL scores were poorer in
hypertensive patients than in general population
[11].
As far as Lebanon is concerned, a population
based study conducted in 2005 revealed that the
overall prevalence of declared hypertension was
23.1% [13]. Compared to other Mediterranean
countries, Lebanon has a lower prevalence of
hypertension; however, compared to other coun-
tries, [14,15], Lebanon still has a high prevalence
of hypertension. Nevertheless, no study has been
performed regarding the health related quality of
life of hypertensive patients and its correlates.
The objective of this study was to evaluate QOL
of hypertensive patients compared to non-hyper-
tensive subjects in Lebanon and to suggest possible
predictors of their QOL.2. Material and methods
2.1. Study design
This is an observational case control study carried
out in hypertensive patients undergoing treatment
and non-hypertensive individuals. Patients were
randomly selected from those visiting outclinics
of two tertiary care hospitals (Hamoud and Raee
Hospitals). The Institutional Review Board of both
institutions waived the need for an official approval
to perform this observational study, provided itrespected patients autonomy and confidentiality.
The patients were informed about the objectives
of the study and asked to give an oral consent.
Only those who gave their consent to participate
in the study were enrolled. Data were collected
from the 2nd of March till the 1st of June 2014.
2.2. Study population
Patients enrolled were of both genders, aged
18 years and older and divided into two groups:
Hypertensive group consisting of patients diag-
nosed with hypertension and taking antihyperten-
sive medication for at least three months, while
the control group consisted of non-hypertensive
individuals (blood pressure < 120/90 mmHg); the
latter should be healthy or consulting for acute
health related problems, such as urinary tract
infections or otitis. Exclusion criteria were the
presence of chronic or disabling diseases, including
decompensated diabetes, cancer, pregnancy,
sequelae of stroke, decompensated heart failure,
chronic kidney disease, liver failure, acute myocar-
dial infarction within the past six months and the
use of antipsychotic drugs.
2.3. Data collection
Data were acquired through a structured face to
face interview. The questionnaire was administered
in Arabic and included different sections that eval-
uated: socio-demographic data including sex, age,
educational level and marital status, monthly
income, bodymass index and lifestyle data including
smoking status, involvement in sports activities,
alcohol, caffeine consumption and salt intake.
Detailed health history was also assessed, in relation
with the onset of the hypertension, the presence of
associated complications and co-morbidity. Clinical
data related to hypertension classification (con-
trolled or uncontrolled), pharmacological manage-
ment (class and number of antihypertensive drugs
used) as well as any drug side-effects experienced
were obtained. Blood pressure was recorded.
Accordingly, controlled blood pressure was defined
as systolic blood pressure 6 140 mmHg and
diastolic 6 90 mmHg [16]. We also assessed the
patients attitudes and knowledge about the sever-
ity of disease and the use of medication.
2.4. Quality of life measurement
We assessed the QOL using the SF-8 questionnaire.
While one of the most widely used tools is the SF-
36 generic QOL questionnaire, its derivative (SF-8)
is an additional easier instrument used in
Hypertension in the Lebanese adults: Impact on health related quality of life 329population-based studies andwould provide a candi-
date instrument for measuring QOL in hypertensive
patients [12]. This questionnaire offers the advan-
tage that scores can be readily compared with
results from the original SF-36 version. Moreover,
it represents a major advance in measuring QOL
for purposes of achieving both brevity and compre-
hensiveness in population health surveys. [12].
SF-8 has eight items, relying on a single item to
measure each of the eight domains of health in the
SF-36 survey: physical functioning, physical role,
bodily pain, general health, vitality, social func-
tioning, emotional role and mental health.
Physical functioning covers limitations in daily life
due to health problems. The role physical scale
measures role limitations due to physical health
problems. The bodily pain scale assesses pain fre-
quency and pain interference with usual roles.
The general health scale measures individual per-
ceptions of general health. The vitality scale
assesses energy levels and fatigue. The social func-
tioning scale measures the extent to which ill
health interferes with social activities. The role
emotional scale assesses role limitations due to
emotional problems, and the mental health scale
measures psychological distress [12].
The SF-8 was thus translated into Arabic by a
bilingual Lebanese researcher, the main language
of Lebanon. It is then back translated into English
by another translator who has no knowledge of
the English version. Forward translation into
Arabic was conducted. The Arabic version was then
pilot-tested for understanding in a small patient
group before it was used. Its psychometric proper-
ties were also assessed in the Lebanese population.
2.5. Sample size
Sample size was calculated using Epi info7, assum-
ing a type I error of 5% and a study power of 80%
and a confidence interval of 95%. In the absence
of baseline data, the exposure probability to hyper-
tension was considered to be equal to 50% in
healthy population. The minimal sample size
necessary to show a twofold increase in the risk
of hypertension consisted of 336 subjects. We
decided to study about twice this number in a ratio
case/control = 1/2 to have an adequate power for
studying subgroups.
2.6. Statistical analysis
Data were entered and analyzed using Statistical
Package for Social Sciences, version 19. No missing
data were obtained. A p-value 6 0.05 was consid-
ered significant in all tests. Quality control of dataentry and cleaning were done. Descriptive statistics
including frequency, mean, and standard deviation
were used to summarize patients characteristics.
After data cleaning, items quality was assessed
by analyzing the distribution of item responses of
the SF-8 using aggregate endorsement frequencies.
For instruments with around a 5 point response
range such as the SF-8, any item with 2 or more
adjacent response points showing less than 10% of
the response on aggregate are problematic [17].
The QOL score was also validated by testing for
inter-item correlation. The internal consistency of
the SF-8 was assessed using Cronbachs reliability
coefficient alpha. Internal consistency of SF-8
items with the underlying constructs of physical
component summary (PCS) and mental component
summary (MCS) was assessed using Pearson cor-
relation test [18]. It was hypothesized that there
would exist strong correlations between the PCS
and items 1–5, and strong correlations between
MCS and items 6–8 assuming that items more clo-
sely related to a common dimension would show
a correlation ofP 0.50.
The major dependent variable was PCS, MCS,
and overall QOL which is the sum of all individual
domains of SF-8 items. Each domain was scored
over 100 using a norm-based scoring method [19].
When PCS and MCS measures were calculated,
higher summary scores indicated better health.
Scores above and below 50 were considered above
and below the average based upon results recorded
by the developers of the SF-8 [12].
An appropriate bivariate analysis was done for
every explanatory variable. For continuous vari-
ables used in comparison, we used Student test
or ANOVA for variables with adequate normal dis-
tribution to compare between means. For non-nor-
mally distributed continuous variables, the
Kruskal–Wallis test was used. For categorical vari-
ables, Chi2 and Fisher exact tests were used to
compare percentages.
Multivariable analysis using linear regression was
carried out to compare measures between groups
of comparison, taking into account potential con-
founding variables that had a p < 0.20 in bivariate
analysis. The analysis sought to explore factors
associated with QOL using regression analysis.
The final model was accepted after ensuring ade-
quacy of data.3. Results
During the study period, the number of subjects
that agreed to participate in this study was 672
(out of 785; 85.6%); among them, 224 patients
330 M. Khalifeh et al.(33.3%) were included in the hypertension group
and 448 (66.7%) in the control group. Patients
who refused to participate did not deliver any
information to the researcher.
3.1. SF-8 data quality, internal consistency
and reliability
The response distributions of each item for the
sensitivity aggregate endorsement frequency
showed all 8 items performing well. Table 1 shows
that no item of the SF-8 questionnaire has 2 or
more adjacent responses showing < 10% of
responses. Internal consistency measured by
Pearson correlation is also presented in Table 1.
These show a generally strong level of consistency
(P0.60) of items 1–5 with PCS including general
health (r = 0.744), physical functioning
(r = 0.858), role physical limitation (r = 0.884),
bodily pain (r = 0.765), and vitality (r = 0.765).
Also, the results show strong correlation items 6–
8 with MCS including social functioning (r = 0.5),
mental health (r = 0.914), emotional role
(r = 0.852).
Reliability Cronbachs alpha of the model (SF-8)
was 0.868 with average intraclass correlation coef-
ficient (ICC) = 0.868 (95%CI = 0.853–0.883;
p < 0.001). Cronbachs alpha of each of the two
summaries PCS was 0.882 and that of MCS was
0.763 which is very high (>0.7). Moreover, the
removal of any item of the score was accompanied
by a decrease in the models Cronbachs alpha.
3.2. Socio-demographic characteristics
of the study population
The comparison of characteristic differences
between hypertension and control groups is shown
in Table 2. Both groups were homogenous regard-
ing gender (p = 0.557). Participants were mostlyTable 1 Distribution of frequencies & internal consistency of
QOL items Response option frequencies in N (%)
1 2 3
General health 41 (6.1%) 167 (24.9%) 233 (34.7
Physical functioning 205 (30.5%) 192 (28.6%) 148 (22%)
Role physical
limitation
199 (29.6%) 184 (27.4%) 165 (24.6
Bodily pain 236 (35.1%) 88 (13.1%) 103 (15.3
Vitality 69 (10.3%) 227 (33.8%) 273 (40.6
Social functioning 296 (44%) 153 (22.8%) 127 (18.9
Mental health 206 (30.7%) 107 (15.9%) 172 (25.6
Role emotional
limitation
316 (47%) 142 (21.1%) 124 (18.5females in hypertension and control groups
(59.00% versus 62.27%). Hypertension individuals
were older, less educated, widowed or divorced,
retired or never working, have less monthly income
and more financial support and were more over-
weight and obese (p < 0.001).
3.3. Health related quality of life
Controls had higher significant scores (p < 0.05)
than hypertensive individuals in all domains of
the QOL score. Controls showed better QOL in gen-
eral health, physical functioning, role physical
limitation, bodily pain, vitality, and PCS with
(p < 0.001). They also showed better health perfor-
mance in mental health related items including
social functioning (p = 0.033), mental health
(p = 0.011), emotional limitation role (p < 0.001),
and MCS (p = 0.026) (Fig. 1).
3.4. Multivariable analyses
In the multivariable linear regression model
(Table 3), we found that the presence of hyperten-
sion (b = 17.241, p = 0.009, 95%CI: [30.166,
4.317]) and mood disorder (b = 17.241,
p < 0.001, 95%CI: [58.011, 16.661]) were nega-
tively associated to QOL. Increasing age
(b = 0.388, p < 0.001, 95%CI: [7.52, 0.24])
and female gender (b = 14.485, p = 0.037,
95%CI: [23.323, 5.648]) also significantly
affected QOL where females had lower QOL than
males. Practicing regular sport (b = 15.937, 95%CI:
[6.362, 25.513]) and higher education level
(b = 15.937, 95%CI: [8.451, 27.68]) were positively
associated to QOL (p < 0.001). Moreover, the pres-
ence of more comorbidities was adversely corre-
lated the overall QOL (b = 8.083, p = 0.009,
95%CI: [14.184, 1.982]). The frequency of med-
ication intake/day was the most significant riskSF-8 (N = 672).
Internal
consistency
4 5 6 r PCS r MCS
%) 150 (22.3%) 69 (10.3%) 12 (1.8%) 0.744 0.315
113 (16.8%) 14 (2.1%) 0.858 0.194
%) 102 (15.2%) 22 (3.3%) 0.884 0.226
%) 156 (23.2%) 81 (12.1%) 8 (1.2%) 0.765 0.286
%) 95 (14.1%) 8 (1.2%) 0.636 0.407
%) 93 (13.8%) 3 (0.4%) 0.409 0.500
%) 164 (24.4%) 23 (3.4%) 0.153 0.914
%) 83 (12.4%) 7 (1%) 0.196 0.852
Table 2 Socio-demographic characteristics of the study population.
Characteristics Hypertension group N = 224 Control group N = 448 P-value
Age in years mean (SD) 59.53 (12.08) 40.57(13.23) <0.001
Sex n (%)
Males 90 (40.17%) 169 (37.72%) 0.557
Females 134 (59%) 279 (62.27%)
Educational level: n (%)
Illiterate 30 (13.39%) 12 (2.67%) <0.001
Elementary 73 (32.25%) 54 (12.05%)
Intermediate 56 (25,00%) 100 (22.32%)
Secondary 25 (11.16%) 92 (20.53%)
University 40 (17.80%) 190 (42.41%)
Marital status: n (%)
Single 11 (4.91%) 87 (19.41%) <0.001
Married 183 (81.69%) 354 (79.01%)
Divorced/widowed 30 (13.39%) 7 (1.56%)
Employment: n (%)
Unemployed 138 (61.61%) 195 (43.52%) <0.001
Employed 60 (26.78%) 239 (53.34%)
Retired 26 (11.61%) 14 (3.12%)
Working hours: n (%)
None 160 (71.42%) 207 (46.21%) <0.001
[3–8] h 29 (12.94%) 85 (12.27%)
[7–16] h 35 (15.62%) 156 (34.82%)
Monthly income: n (%)
[500,000–1,000,000 L.L.] 98 (43.75%) 116 (25.89%) <0.001
[1,000,000–2,000,000 L.L.] 94 (41.96%) 239 (53.34%)
[>2,000,000 L.L.] 32 (14.28%) 93 (20.75%)
Living: n (%)
Alone 37 (16.51%) 13 (2.9%) <0.001
With family 187 (83.48%) 435 (97.09%)
Financial support: n (%)
Yes 146 (65.7%) 89 (19.86%) <0.001
No 78 (34.82%) 359 (80.13%)
BMI*: mean (SD) 28.324 (4.604) 26.113 (3.724) <0.001
Underweight n (%) 0 (0%) 4 (0.89%)
Normal n (%) 53 (23.66%) 178 (39.73%)
Overweight n (%) 109 (48.66%) 202 (45.08%)
Obese n (%) 62 (27.67%) 64 (14.28%)
Data presented as mean (SD) and number (%) were performed using T test and Chi2 respectively and a p-value < 0.05 is considered
significant.
* Body mass index.
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p = 0.001, 95%CI: [18.673, 4.531]) where
patients with lower frequency of medication had
better QOL.
In the multivariable linear regression model
estimating the predictors of PCS (Table 3), we
found that the frequency of medications/day was
the most significant inverse correlate
(b = 11.602, p = 0.001, 95%CI: [3.139, 1.01]).Age (b = 0.117, 95%CI: [0.173, 0.061]) and
gender (b = 2.555, 95%CI: [4.115, 0.995]) were
also inversely correlated with PCS (p < 0.001).
Regular sport (b = 3.461, p < 0.001, 95%CI: [2.002,
4.921]) and education (b = 2.415, p = 0.001,
95%CI: [0.934, 3.897]) were positively correlated
with PCS, while working effect was not statistically
significant (p = 0.076). Moreover, comorbidities
were adversely associated with PCS (b = 3.631,
010
20
30
40
50
60
Hypertension
Control
Fig. 1 Mean scores of each SF-8 domain, comparing hypertension and control groups. Data are presented as means;
statistical significance was tested using T test, all p-values were < 0.05.
Table 3 Multivariable Analysis of QOL score and its components.
Predictors Un stand. b Stand. b 95%CI lower upper p-Value
Linear regression; dependent variable: QOL overall
Hypertension 17.241 0.128 30.166 4.317 0.009
Gender 14.485 0.111 23.323 5.648 0.037
Age 0.388 0.095 0.752 0.024 <0.001
Education (University) 18.065 0.134 8.451 27.68 <0.001
Regular sport 15.937 0.109 6.362 25.513 0.001
Number of comorbidities 8.083 0.120 14.184 1.982 0.009
Mood disorder 17.241 0.121 58.011 16.661 <0.001
Frequency of drugs/day 11.602 0.186 18.673 4.531 0.001
Linear regression; dependent variable: physical component (PCS)
Hypertension 2.074 0.144 5.292 1.332 0.001
Gender 2.555 0.114 4.115 0.995 0.001
Age 0.117 0.168 0.173 0.061 <0.001
Education (University) 2.415 0.105 0.934 3.897 0.001
Regular sport 3.461 0.139 2.002 4.921 <0.001
Working hours 1.830 0.760 0.192 3.467 0.076
No cigarette/day 0.053 0.066 1.020 0.005 0.031
Presence of comorbidity 3.631 0.166 5.385 1.878 <0.001
Mood disorder 3.250 0.062 6.435 0.660 0.045
Frequency of drugs/day 2.074 0.195 3.139 1.010 <0.001
Linear regression; dependent variable: mental component (MCS)
Regular sport 1.932 0.077 0.091 3.774 0.04
Smoking waterpipe 2.555 0.081 4.908 0.202 0.033
Drinking coffee 3.084 0.094 5.498 0.671 0.012
Mood disorder 7.582 0.143 11.502 3.663 <0.001
Frequency of drugs/day 1.940 0.181 2.746 1.134 <0.001
CI: confidence interval, p < 0.05 is considered significant, b: regression coefficient.
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hypertension (b = 2.074, 95%CI: [5.292,
1.332]) and mood disorders (b = 17.241, 95%CI:
[6.435, 0.66]) were negatively associated with
PCS (p < 0.001). In addition, higher daily cigarettes
reduced PCS significantly (b = 0.053, p = 0.031,
95%CI: [1.02, 0.005]).
In the multivariable linear regression model
estimating the predictors of MCS (Table 3), regular
sport was positively associated with MCS
(b = 1.932, p < 0.05, 95%CI: [0.091, 3.774]). The
frequency of medications/day was the most signifi-
cant risk factor to be negatively correlated with
MCS (b = 1.94, p < 0.001, 95%CI: [2.746,
1.134]). The presence of mood disorders signifi-
cantly lowered MCS (b = 7.582, p < 0.001, 95%CI:
[11.502, 3.663]). Moreover, smoking waterpipe
(b = 2.555, p = 0.033, 95%CI: [4.908, 0.202])
and drinking coffee (b = 3.084, p = 0.012, 95%CI:
[5.498, 0.671]) were associated with lower
MCS scores.
3.5. Intragroup analysis of QOL:
hypertensive individuals
Female gender and age were significantly associ-
ated with lower QOL (b = 21.363 p = 0.001,
95%CI: [34.353, 8.374] and b = 0.548,
p = 0.044, 95%CI: [1.08, 0.016], respectively).
Higher education level (b = 22.949, p = 0.006,
95%CI: [6.798, 38.101]) and regular sport
(b = 23.15, p < 0.001, 95%CI: [9.969, 36.33]) were
positively associated with QOL. The presence of
drugs side effects (b = 19.262, p = 0.031, 95%CI:
[36.702, 1.822]) and of comorbidities
(b = 13.865, p = 0.054, 95%CI: [27.992, .262])
were negatively associated with overall QOL.
Moreover, the increase in daily cigarettes
(b = 0.726, p < 0.001, 95%CI: [1.127, 0.324])
and salt consumption (b = 15.728, p = 0.049,
95%CI: [31.418, 0.038]) was adversely corre-
lated with overall QOL. The frequency of med-
ications/day (b = 8.193, p = 0.058, 95%CI:
[16.669, 0.282]) also reduced the overall QOL.
(Table 4).
In the multivariable linear regression model
estimating the predictors of PCS (Table 4), female
gender (b = 4.308, p = 0.006, 95%CI: [34.353,
8.374]) and older age (b = 0.241, p < 0.001,
95%CI: [1.08, 0.16]) were strongly and inversely
associated with PCS. Practicing regular sport
(b = 23.15, p = 0.017, 95%CI: [9.969, 36.33]) and
increasing working hours (b = 4.493, p = 0.022,
95%CI: [0.647, 8.339]) were positively correlated
with PCS. Moreover, the number of cigarettes/day
(b = 0.101, p = 0.016, 95%CI: [0.184, 0.019])as well as the frequency of medication taken /
day were negatively associated with PCS
(b = 1.595, but p = 0.079). Dyslipidemia negatively
affected PCS (b = 4.493, p = 0.001, 95%CI:
[7.259, 2.009]). In addition, angiotensin con-
verting enzyme inhibitors/angiotensin receptors
blockers (b = 3.663, p = 0.049, 95%CI: [0.012,
5.314]) and combination drugs had positive sta-
tistically significant correlation with PCS
(b = 2.998, p = 0.03, 95%CI: [0.285, 5.712]).
However, understanding the severity of the disease
was associated with significant negative associa-
tion on PCS (b = 5.019, p = 0.037, 95%CI:
[9.735, 0.303]).
In the multivariable linear regression model
estimating the predictors of MCS (Table 4), regular
sport was positively correlated with MCS
(b = 1.932, p = 0.03, 95%CI: [0.34, 6.752]).
Increasing the number of cigarette/day was the
most significant risk factor negatively associated
with MCS (b = 0.117, p = 0.015, 95%CI: [0.211,
0.032]). Drugs side effects were negatively corre-
lated with MCS (b = 4.584, p = 0.003, 95%CI:
[8.799, 0.369]).4. Discussion
The SF-8 health survey was internally consistent
and a reliable tool for the assessment of the quality
of life of patients in Lebanon. Hypertensive
patients had a poor QOL with lower scores in all
domains of the SF-8 in comparison with non-hyper-
tensive individuals in both physical and mental
domains, taking into account differences in other
characteristics. Although this study contradicts
the traditional concept that claims hypertension
as an asymptomatic disease, it is consistent with
studies that demonstrate the impact of hyperten-
sion on QOL [9–11]. The clinical significance of
these differences in QOL is established [12]: given
that differences found between hypertensive and
control individuals were well above 2 for all physi-
cal components items (11 points on PCS), and
between 2 and 3 for mental component items,
hypertension seems to affect mainly affect physi-
cal health in the Lebanese population.
Moreover, the present study showed QOL was
affected by several factors: hypertensive males
and younger individuals had better QOL, which cor-
roborates the data obtained by Bardage and Isacson
[11]. For men the QOL score was better in all
domains. The facts that men had better QOL scores
may be possibly due to them being more tolerant to
chronic diseases, thus less emotionally affected by
them when compared to women [11]. With regard
Table 4 QOL predictors among hypertensive patients.
Predictors Un stand. b Stand. b 95%CI lower upper p-Value
Linear regression (in hypertension group) dependent variable: QOL overall
Gender 21.363 0.196 34.353 8.374 0.001
Age 0.548 0.123 1.080 0.016 0.044
Education (University) 22.949 0.164 6.798 38.101 0.006
Regular sport 23.150 0.199 9.969 36.33 <0.001
Drugs side effects 19.262 0.125 36.702 1.822 0.031
Presence of comorbidity 13.865 0.117 27.992 0.262 0.054
Frequency of drugs/day 8.193 0.12 16.669 0.282 0.058
High Salt consumption 15.728 0.112 31.418 0.038 0.049
Linear regression (in hypertension group) dependent variable: physical component (PCS)
Gender 4.308 0.185 7.286 1.330 0.006
Age 0.241 0.241 0.353 0.130 <0.001
Regular sport 4.200 0.170 1.474 7.926 0.017
Working hours 4.493 0.143 0.647 8.339 0.022
Number of cigarettes/day 0.101 0.138 0.184 0.019 0.016
Frequency of drugs/day 1.595 0.110 3.374 0.185 0.079
Dyslipidemia 4.493 0.203 7.259 2.009 0.001
Angiotensin related drugs 3.663 0.112 0.012 5.314 0.049
Combination 2.998 0.121 0.285 5.712 0.03
Understand severity of hypertension 5.019 0.117 9.735 0.303 0.037
Linear regression (in hypertension group) dependent variable: mental component (MCS)
Regular sport 3.546 0.144 0.340 6.752 0.030
Number of cigarettes/day 0.117 0.159 0.211 0.032 0.015
Drugs side effect 4.584 0.141 8.799 0.369 0.033
CI: confidence interval, p < 0.05 is considered significant, b: regression coefficient.
334 M. Khalifeh et al.to age, younger hypertensive patients had better
QOL: in fact, during the aging process, health haz-
ards may arise as a result of physiological changes,
making the individual more prone to chronic dis-
eases which can affect QOL [10]. Patients with a
higher level of education had higher QOL scores
in overall QOL and PCS. The level of education
influences the ability to understand information,
which favors knowledge on the disease and treat-
ment adherence. Therefore, patients with a higher
level of education may have better QOL scores
[20]. Individuals with employment status and
higher working hours also had higher QOL scores
in the physical domain and this finding is in agree-
ment with other study [21].
Furthermore, the dimensions of the QOL score
were found to be significantly associated with
many lifestyle factors. Smoking was significantly
and negatively associated with QOL in the selected
population as well as the magnitude of this associa-
tion was determined by the number of cigarettes
smoked. Waterpipe smoking was also significantly
associated with poorer mental score outcomes,
possibly associated with a number of deleterious
health outcomes due to the withdrawal effect of
high nicotine concentrations. This finding is similarto those reported by Wilson et al. [22]. However,
regular sport was significantly and positively corre-
lated with QOL in all domains. Remaining physically
active can enhance functional capacity and mental
well-being to maintain QOL and independence.
Besides, caffeine was negatively associated with
MCS score. Caffeine is known to elevate systolic
blood pressure and diastolic blood pressure at rest
and during mental and exercise stress [23]. In addi-
tion, high salt consumption was shown to reduce
QOL significantly in hypertensive group. A strong
association between increased sodium intake and
blood pressure has been shown to be correlated
with QOL [24]. This leads to stronger enthusiasm
for strict control of sodium intake for hypertensive
people.
As expected, the presence of comorbidities was
associated with lower QOL in hypertensive
patients. This finding is consistent with that of
Wang et al. [19], showing a greater decline in func-
tioning than those with only one condition.
Depression and anxiety were significantly more
associated with lower score of QOL. This is due to
the negative effect of depression on mood perfor-
mance and eventually on the functional capacity.
Also, we observed that dyslipidemia significantly
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to the negative effect of dyslipidemia on the physi-
cal performance. These findings suggest that effec-
tive treatment and prevention of chronic diseases
may be important to preserve the QOL; the latter
suggestion remains to be established in adequate
prospective studies.
As for medications, the use of angiotensin con-
verting enzyme inhibitors, angiotensin receptor
blockers and drug combinations improved the physi-
cal score. This finding is in concordance with a pre-
vious study that analyzed selected aspects of the
QOL such as physical performance [25]. However,
b blockers may actually worsen the QOL [26], which
is consistent with our results. Of the drugs evaluated
in our study, calcium channel blockers and diuretics
appeared to have non-significant effects on the QOL
and were associated only with a decline in physical
health. The present study also revealed a significant
unfavorable influence of drug side-effects on quality
of life, particularly in overall QOL and MCS. Studies
show that there is a deficit in the QOL of hyperten-
sive patients because of the adverse effects of the
drugs used in the antihypertensive treatment [9].
It is therefore essential for clinicians to select the
drug best tolerated by individual patients to balance
their needs with the best quality of life. Moreover,
the increase in the dose frequency per day and the
increased number of prescribed medications were
the primary factors associated with lower QOL in
hypertensive patients. This is consistent with
another study suggesting that the overuse of med-
ications decrease the QOL [19]. The use of over-
the-counter medications was also associated with
lower QOL, probably because of the perception of
overmedication or the consequences of adverse
effects on hypertensive patients. Knowledge of the
hypertension severity was significantly correlated
with PCS, perhaps because patients felt stigmatized
after discovering that they had the disease.
Moreover, neither drug cost per patient, nor the
presence of a medical insurance could predict the
QOL. This finding is supported by evidence from
literature [27]. Finally, when evaluating the influ-
ence of the number of antihypertensive drugs, the
controlled status of BP and the duration of hyperten-
sion on QOL, no significant difference were found in
any of the domains studied. However, another study
verified that hypertensive patients who were under
treatment and whose BP levels were under control
had higher QOL than those with uncontrolled blood
pressure [10]. This discrepancy may be explained
by the low subsample size.
Although our study has several points of
strength, since this is the first study that formallyassesses the QOL of hypertensive patients com-
pared with general individuals in Lebanon, it has
several limitations. To begin with, it is a cross-sec-
tional study; therefore, it does not allow causality
to be attributed to the observed associations. The
baseline characteristics differ between the hyper-
tension and control group; this may introduce
potential confounding factors that were taken into
account during multivariable analyses; however,
residual confounding may still be possible, due to
confounders that we may have not adequately
measured. Moreover, there could also be a possibil-
ity of respondent and information bias, since the
results of our study were based on a face to face
questionnaire. Another study limitation was the
incapacity to assess the influence of the antihyper-
tensive drug associations on QOL of hypertensive
individuals due to the large number of combina-
tions. In addition, the lower than expected preva-
lence of common diseases (e.g., peripheral artery
disease, neuronal diseases, chronic venous insuffi-
ciency) may suggest that polymorbidity was under-
reported. However, since the associations we
found were all consistent with the literature and
of biological plausibility, we have no reason to
believe that our results suffer from serious
methodological flaws.
5. Conclusion
In Lebanon hypertensive patients presented a
lower QOL scores in all domains of SF-8 than non-
hypertensive individuals. Therefore, it is essential
to find medical and social alternatives that have a
favorable influence on QOL; this can be achieved
by the development of drugs that provide blood
pressure control and favorable effects on QOL with
minimal side effects. Hence, effective health
interventions should ensure maintenance of desir-
able QOL in order to prevent or reduce comorbidi-
ties of hypertension. There is a necessity for health
professionals to take these factors into account
when treating hypertensive patients, and to tackle
special subgroups with attention to their deterio-
rated QOL.
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